OOIR: Observatory of International Research

Papers

(The H4-Index of Brain is 70. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Reply: Is postural tachycardia syndrome a psychogenic disorder?; Notes on establishing fear conditioning as causal in the postural orthostatic tachycardia syndrome; Patients with POTS fear that data o	343
The axon initial segment as a source of neuropathic pain	332
De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features	292
Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum	281
Impaired ribosome-associated quality control of C9orf72 arginine-rich dipeptide-repeat proteins	170
Correction to: Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders	164
Proust and his neurologists: the challenge of functional disorders	164
Thalamostriatal disconnection underpins long-term seizure freedom in frontal lobe epilepsy surgery	164
Methodological drawbacks in the alleged association between foetal sonographic anomalies and autism	164
Dysregulated cortical excitability and tau phosphorylation in a β3 integrin mouse model of autism	155
Lesion correlates of impaired acoustic-phonetic perception after unilateral left hemisphere stroke	154
Clinical and genetic characterization of a progressive RBL2-associated neurodevelopmental disorder	149
Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation	147
Dysfunction of the magnocellular subdivision of the visual thalamus in developmental dyslexia	145
Clinical and genetic spectrum of 355 Chinese children with epilepsy: a trio-sequencing-based study	136
Associations between accelerated forgetting, amyloid deposition and brain atrophy in older adults	136
Deep brain stimulation: a tale of two targets … and closing the loop	136
Trigeminal nerve microstructure is linked with neuroinflammation and brainstem activity in migraine	133
Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1	127
Somatic variants of MAP3K3 are sufficient to cause cerebral and spinal cord cavernous malformations	126
Source-sink connectivity: a novel interictal EEG marker for seizure localization	124
Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease	124
18F-MK-6240 tau-PET in genetic frontotemporal dementia	123
The inferior fronto-occipital fasciculus: bridging phylogeny, ontogeny and functional anatomy	121
3T MRI of rapid brain activity changes driven by subcallosal cingulate deep brain stimulation	121

We’re all in this together: a rejoinder to Masud Husain’s (rant) editorial	121
The efficacy and deficiency of contemporary treatment for spinal cord arteriovenous shunts	120
Biallelic ADAM22 pathogenic variants cause progressive encephalopathy and infantile-onset refractory epilepsy	117
The use of optical coherence tomography in neurology: a review	113
Biallelic FRA10AC1 variants cause a neurodevelopmental disorder with growth retardation	109
Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline	106
‘Seeding’ the idea of early diagnostics in synucleinopathies	105
Mapping the peripheral immune landscape of Parkinson’s disease patients with single-cell sequencing	103
Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease	102
Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development	102
Brain repair mechanisms after cell therapy for stroke	101
Diffusion MRI tracks cortical microstructural changes during the early stages of Alzheimer’s disease	100
From bugs to brain: unravelling the GABA signalling networks in the brain–gut–microbiome axis	100
A data-driven study of Alzheimer's disease related amyloid and tau pathology progression	92
The vascular contribution of apolipoprotein E to Alzheimer’s disease	91
‘Hippocampal innate inflammatory gliosis only’ in pharmacoresistant temporal lobe epilepsy	88
Genetically identical twin-pair difference models support the amyloid cascade hypothesis	87
Optogenetic stimulation of the superior colliculus suppresses genetic absence seizures	87
Speech and language markers of neurodegeneration: a call for global equity	85
ActivatingRAC1variants in the switch II region cause a developmental syndrome and alter neuronal morphology	84
Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes	83
Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups	83
Correction to: New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy	81
Midbrain cytotoxic T cells as a distinct neuropathological feature of progressive supranuclear palsy	79
Genome-wide association study of neuropathological features in Lewy body disease	79
Hitching a ride on exosomes: a new approach for the delivery of siRNA-mediated therapies	78
Multiple sclerosis in Denmark (1950–2023): mean age, sex distribution, incidence and prevalence	78
Synaptic dysregulation in a mouse model of GRIN2D developmental and epileptic encephalopathy	77
Reply: Unblinding in the lecanemab trial in Alzheimer’s disease	76
The interictal suppression hypothesis is the dominant differentiator of seizure onset zones in focal epilepsy	75
Defective lipid signalling caused by mutations inPIK3C2Bunderlies focal epilepsy	75
Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration	74
Multimodal mapping of regional brain vulnerability to focal cortical dysplasia	74
Long-term neuropsychological trajectories in children with epilepsy: does surgery halt decline?	74
Demystifying interictal discharges and seizure initiation in focal epilepsy	74
Multiple lines of evidence for disruption of nuclear lamina and nucleoporins in FUS amyotrophic lateral sclerosis	74
The three deceits of bureaucracy	73
Evolutionary perspectives on mRNA signatures of neurodegeneration-related brain remodelling	73
Reply: From early limbic inflammation to long COVID sequelae	73
Extra-cranial cholinergic lesions in dementia with Lewy bodies	73
GGC repeat expansions in NOTCH2NLC cause uN2CpolyG cerebral amyloid angiopathy	72
Biallelic null variants in PNPLA8 cause microcephaly by reducing the number of basal radial glia	72
New mechanistic insights into hereditary spastic paraplegias	72
Cytotoxic T cells and plasma cells dominate early in temporal lobe epilepsy with GAD antibodies	72
Functional network reorganization precedes apathy in Parkinson’s disease: a neural marker of risk?	70
Preclinical type 2 diabetes mellitus subtypes: new insights into diabetes, depression and dementia	70
The low dimensionality of post-stroke cognitive deficits: it’s the lesion anatomy!	70
Stuttering associated with a pathogenic variant in the chaperone protein cyclophilin 40	70
BMP receptor blockade overcomes extrinsic inhibition of remyelination and restores neurovascular homeostasis	70